It attenuates pathological ventricular remodeling (versus physiological) in a rat model of pressure overload hypertrophy, as attested by the decreased expression of pathologic cardiac hypertrophy markers ANF and β-MHC, improved sarcomeric function and enhanced Ca++ transient in cardiomyocytes [25]. The gene discussed is NPPA; the disease is cardiac hypertrophy.